| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 15.12B | 15.06B | 16.05B | 17.03B | 18.66B | 18.66B |
| Gross Profit | 3.31B | 3.14B | 2.86B | 2.53B | 2.11B | 2.11B |
| EBITDA | 2.96B | 1.55B | 1.14B | 617.00M | -175.00M | -175.00M |
| Net Income | 249.00M | 252.00M | -340.00M | -1.37B | -2.30B | -2.30B |
Balance Sheet | ||||||
| Total Assets | 11.28B | 10.45B | 10.59B | 11.46B | 13.21B | 13.21B |
| Cash, Cash Equivalents and Short-Term Investments | 450.00M | 1.79B | 1.55B | 1.85B | 2.22B | 2.22B |
| Total Debt | 4.57B | 3.96B | 4.14B | 4.24B | 4.60B | 4.60B |
| Total Liabilities | 9.97B | 9.12B | 9.47B | 10.00B | 10.45B | 10.45B |
| Stockholders Equity | 1.19B | 1.22B | 1.01B | 1.36B | 2.77B | 2.77B |
Cash Flow | ||||||
| Free Cash Flow | -99.00M | 337.00M | -197.00M | -197.00M | -871.00M | -408.00M |
| Operating Cash Flow | 594.00M | 942.00M | 454.00M | 454.00M | -119.00M | 628.00M |
| Investing Cash Flow | -639.00M | -404.00M | -553.00M | -553.00M | -572.00M | -953.00M |
| Financing Cash Flow | -495.00M | -286.00M | -170.00M | -170.00M | 2.92B | 312.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | $12.78B | 23.70 | 13.16% | ― | 12.61% | 11.85% | |
73 Outperform | $6.27B | 14.72 | 21.81% | 1.41% | 7.40% | -14.45% | |
70 Outperform | $226.76B | 26.07 | 36.86% | 2.21% | 4.51% | 21.89% | |
68 Neutral | $7.04B | 30.32 | 10.27% | ― | 14.26% | -15.49% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
59 Neutral | $2.15B | 6.07 | 13.41% | ― | -4.13% | 2143.48% | |
53 Neutral | $2.93B | 26.53 | 20.43% | ― | -1.90% | ― |